These medications share similar mechanisms of action (all activate GLP-1 receptors to slow gastric emptying and regulate blood sugar) which forms the basis for their consolidation in a single litigation proceeding
GLP-1s are not for everyone
For employers that dont currently cover GLP-1 drugs for weight loss, the landscape may continue to shift
To know how GLP-1 medications work, it helps to understand how the glucagon-like polypeptide-1 (GLP-1) hormone functions
Liraglutide was administered to mice after suppression of the gut microbiota by antibiotics
By Product: Ozempic dominates, Tirzepatide products growing fastest Ozempic (semaglutide 0.5mg/1mg/2mg weekly subcutaneous injection) dominated the GLP-1 receptor agonist market with approximately 35.12% market share in 2025, driven by its combination of robust clinical efficacy data, early market entry, broad diabetes label, established prescriber relationships, and expanded off-label use for weight management before Wegovy's commercial scale-up